AAAAAA

   
Results: 1-4 |
Results: 4
No evidence of tumor growth stimulation in human tumors in vitro followingtreatment with recombinant human growth hormone
Authors: Fiebig, HH Dengler, W Hendriks, HR
Citation: Hh. Fiebig et al., No evidence of tumor growth stimulation in human tumors in vitro followingtreatment with recombinant human growth hormone, ANTI-CANC D, 11(8), 2000, pp. 659-664
Superior therapeutic efficacy of N-L-leucyl-doxorubicin versus doxorubicinin human melanoma xenografts correlates with higher tumour concentrations of free drug
Authors: Breistol, K Hendriks, HR Fodstad, O
Citation: K. Breistol et al., Superior therapeutic efficacy of N-L-leucyl-doxorubicin versus doxorubicinin human melanoma xenografts correlates with higher tumour concentrations of free drug, EUR J CANC, 35(7), 1999, pp. 1143-1149
High antitumour activity of ET743 against human tumour xenografts from melanoma, non-small-cell lung and ovarian cancer
Authors: Hendriks, HR Fiebig, HH Giavazzi, R Langdon, SP Jimeno, JM Faircloth, GT
Citation: Hr. Hendriks et al., High antitumour activity of ET743 against human tumour xenografts from melanoma, non-small-cell lung and ovarian cancer, ANN ONCOL, 10(10), 1999, pp. 1233-1240
Cell specific cytotoxicity and structure-activity relationship of lipophilic 1-b-d-arabinofuranosylcytosine (ara-C) derivatives
Authors: Peters, GJ Voorn, DA Kuiper, CM van der Wilt, CL Noordhuis, P Smid, K Myhren, F Sandvold, M Hendriks, HR
Citation: Gj. Peters et al., Cell specific cytotoxicity and structure-activity relationship of lipophilic 1-b-d-arabinofuranosylcytosine (ara-C) derivatives, NUCLEOS NUC, 18(4-5), 1999, pp. 877-878
Risultati: 1-4 |